ArticleNeuro-oncology advances

The glutamine antagonist prodrug JHU-083 slows malignant glioma growth and disrupts mTOR signaling.

Alex Shimura Yamashita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.